Recordati Group

This study tests a drug called pasireotide to help people who have dangerously low blood sugar after weight-loss surgery. About 93 adults will receive either the drug or a placebo for 12 weeks, then all can take the drug for up to 36 more weeks. The goal is to see if pasireotide …

This study follows 206 adults with endogenous Cushing's syndrome who are taking osilodrostat as part of their regular care. Researchers will monitor side effects and how well the drug controls cortisol levels over time. The goal is to better understand the drug's long-term safety…

This study is a registry that collects information from about 429 adults with cold agglutinin disease (CAD) or cold agglutinin syndrome (CAS), a rare condition where the immune system attacks red blood cells in cold temperatures. Researchers will track symptoms, treatments, compl…